Shares of Danaher Co. (NYSE:DHR – Get Free Report) have been given an average rating of “Moderate Buy” by the nineteen brokerages that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $287.16.
DHR has been the topic of a number of analyst reports. Robert W. Baird decreased their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Wells Fargo & Company started coverage on Danaher in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target for the company. Barclays dropped their price objective on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Royal Bank of Canada reduced their target price on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Finally, KeyCorp raised their price target on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd.
View Our Latest Stock Analysis on Danaher
Institutional Trading of Danaher
Danaher Stock Up 1.0 %
Shares of NYSE:DHR opened at $230.12 on Wednesday. The stock has a market capitalization of $166.21 billion, a P/E ratio of 43.92, a price-to-earnings-growth ratio of 4.35 and a beta of 0.83. The stock’s 50-day moving average price is $250.76 and its 200-day moving average price is $258.32. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher has a 12-month low of $215.68 and a 12-month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter last year, the business earned $2.02 earnings per share. The business’s revenue was up 3.1% on a year-over-year basis. On average, equities analysts anticipate that Danaher will post 7.5 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What Are Dividend Challengers?
- Guidewire Software Provides Long-Awaited Buying Opportunity
- How to Evaluate a Stock Before Buying
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- How to Invest in Biotech Stocks
- Fast-Growing Companies That Are Still Undervalued
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.